LadRx Corporation (LADX)
OTCMKTS · Delayed Price · Currency is USD
0.1300
0.00 (0.00%)
Nov 18, 2025, 4:00 PM EST
LadRx Market Cap
LadRx has a market cap or net worth of $64.36 thousand as of November 19, 2025. Its market cap has decreased by -91.03% in one year.
Market Cap
64.36K
Enterprise Value
-142.59K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.13
Market Cap Chart
Since April 5, 1988, LadRx's market cap has decreased from 83.03M to 64.36K, a decrease of -99.92%. That is a compound annual growth rate of -17.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 64.36K | -92.26% |
| Dec 31, 2024 | 831.76K | 29.23% |
| Dec 29, 2023 | 643.62K | -87.57% |
| Dec 30, 2022 | 5.18M | -73.55% |
| Dec 31, 2021 | 19.58M | -69.32% |
| Dec 31, 2020 | 63.84M | 554.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 724.59M |
| Glass House Brands | 512.09M |
| American Oncology Network | 369.77M |
| Northwest Biotherapeutics | 368.68M |
| CytoDyn | 333.83M |
| Silence Therapeutics | 322.61M |
| Nika Pharmaceuticals | 311.89M |